This retrospective, single-center study assessed the prognostic value of several emerging inflammatory markers as predictors of in-stent restenosis (ISR) after drug-eluting stent implantation for coronary chronic total occlusion (CTO) lesions. Consecutive patients (n = 416) who underwent successful percutaneous coronary intervention (PCI) for documented CTO lesions and with follow-up angiography were enrolled. Preprocedural high-sensitivity C-reactive protein (hsCRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and red cell distribution width (RDW) were analyzed. At mean follow-up of 14.4 ± 3.3 months, ISR occurred in 72 patients. Compared with the non-ISR group, preprocedural hsCRP level, PLR, NLR, and RDW were significantly higher in the ISR group. The ISR group also had significantly greater proportions of patients with diabetes and smoking history, lower estimated glomerular filtration rate, higher low-density lipoprotein cholesterol (LDL-C) level and neutrophil count, longer stent length, and higher rate of severe dissection. In multivariate analysis, NLR (odds ratio [OR]: 3.110; 95% confidence interval [CI], 2.102-4.063; P < .001) and PLR (OR: 1.029; 95% CI, 1.016-1.143; P < .001) were independent predictors of ISR, along with LDL-C level and stent length. In conclusion, higher preprocedural NLR and PLR levels were independent risk factors for the development of ISR in patients who underwent PCI for CTO lesions.
WernerGSSurberRKuetheF. Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion. Am Heart J. 2005;149:129–37.
2.
KhanMFWendelCSThaiHMMovahedMR. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2013;82:95–107.
3.
LeeSPShinDHParkKW. Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents. Int J Cardiol. 2012;156:180–5.
4.
LiuWWagatsumaKNiiHTodaMAmanoHUchidaY. Impact of diabetes on long term follow-up of elderly patients with chronic total occlusion post percutaneous coronary intervention. J Geriatr Cardiol. 2013;10:16–20.
5.
Al-LameeRIelasiALatibA. Clinical and angiographic outcomes after percutaneous recanalization of chronic total saphenous vein graft occlusion using modern techniques. Am J Cardiol. 2010;106:1721–7.
6.
PratiFDi MarioCMoussaI. In-stent neointimal proliferation correlates with the amount of residual plaque burden outside the stent: an intravascular ultrasound study. Circulation. 1999;99:1011–4.
7.
KurtulAMuratSNYarliogluesM. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease. Platelets. 2015;26:48–52.
8.
ChangZZhengJLiuZGuoQ. The relationship between the neutrophil-lymphocyte ratio and in-stent restenosis in patients with femoropopliteal chronic total occlusions. Angiology. 2018;69(2):177–82.
9.
LiCZhangFShenY. Impact of neutrophil to lymphocyte ratio (NLR) index and its periprocedural change (NLRDelta) for percutaneous coronary intervention in patients with chronic total occlusion. Angiology. 2017;68:640–6.
10.
YilmazSSenFUnalS. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis. Scand Cardiovasc J. 2015;49:39–44.
11.
ZurakowskiAWojakowskiWDzielskiT. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting. Kardiol Pol. 2009;67:623–30.
12.
NoguchiTMiyazakiMSMoriiIDaikokuSGotoYNonogiH. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Catheter Cardiovasc Interv. 2000;49:258–64.
13.
DangasGDClaessenBECaixetaASanidasEAMintzGSMehranR. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56:1897–907.
14.
AlfonsoFByrneRARiveroFKastratiA. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63:2659–73.
15.
ScheinowitzMShouMBanaiSGertzSDLazarousDFUngerEF. Neointimal proliferation in canine coronary arteries. A model of restenosis permitting local and continuous drug delivery. Lab Invest. 1994;71:813–9.
16.
JukemaJWVerschurenJJAhmedTAQuaxPHRestenosis afterPCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol. 2011;9:53–62.
17.
AcetHErtasFAkilMA. Relationship between hematologic indices and global registry of acute coronary events risk score in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2016;22:60–8.
18.
BuffonALiuzzoGBiasucciLM. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999;34:1512–21.
19.
FerranteGNiccoliGBiasucciLM. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med. 2008;9:156–65.
20.
MincuRIJanosiRAVinereanuDRassafTTotzeckM. Preprocedural C-reactive protein predicts outcomes after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction a systematic meta-analysis. Sci Rep. 2017;7:41530.
21.
ParkDWLeeCWYunSC. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation. Heart. 2007;93:1087–92.
22.
BaltaSOzturkCBaltaI. The neutrophil-lymphocyte ratio and inflammation. Angiology. 2015;67:298–9.
23.
SparkJISarveswaranJBlestNCharalabidisPAsthanaS. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg. 2010;52:632–6.
24.
BianCWuYShiY. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels. 2010;25:469–73.
25.
IsikTAyhanEUyarelH. Association of neutrophil to lymphocyte ratio with presence of isolated coronary artery ectasia. Turk Kardiyol Dern Ars. 2013;41:123–30.
26.
OkyayKYilmazMYildirirA. Relationship between neutrophil-to-lymphocyte ratio and impaired myocardial perfusion in cardiac syndrome X. Eur Rev Med Pharmacol Sci. 2015;19:1881–7.
27.
LiZCuiLMaJMaXLiG. Association between neutrophil to lymphocyte ratio and atrial fibrillation. Int J Cardiol. 2015;187:361–2.
28.
BaltaSCelikTMikhailidisDP. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22:405–11.
29.
TurakOOzcanFIsleyenA. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol. 2012;110:1405–10.
30.
NikolskyEGrinesCLCoxDA. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2007;99:1055–61.
31.
ZouridakisEGGarcia-MollXKaskiJC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol. 2000;86:449–51.
32.
GaryTPichlerMBelajK. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013;8:e67688.
33.
AkbogaMKCanpolatUYaylaC. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67:89–95.
34.
YildizAYukselMOylumluM. The utility of the platelet-lymphocyte ratio for predicting no reflow in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2015;21:223–8.
35.
TemizAGaziEGungorO. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014;20:660–5.
36.
AzabBShahNAkermanMMcGinnJTJr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012;34:326–34.
37.
WeissGGoodnoughLT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–23.
38.
YildizATekinerFKarakurtASirinGDumanD. Preprocedural red blood cell distribution width predicts bare metal stent restenosis. Coron Artery Dis. 2014;25:469–73.
